A critical component of our medicinal product development is clinical research, including the evaluation of safety and efficacy. Our medicines and products only matter if they are accessible to everyone who needs them, when they need them.
As a global biopharmaceutical company, we have a responsibility to the patients and customers who depend on our medicines and products. That’s why we hold ourselves to high standards of quality and safety.
Ensuring quality is everyone’s job so that we can deliver a consistent stream of innovative medicines and products and have a lasting impact on people’s lives.
In our culture of quality, if you SEE something, SAY something, DO something.
If we focus on quality and flawless execution, compliance will follow. We empower all employees to be critical, constructive and uphold AbbVie to the highest standards of quality, every day.
Our pride in product quality and commitment to patient safety are a powerful combination that motivates employees to stay vigilant, speak up and be part of the solution.
Our pharmacovigilance and patient safety teams identify potential safety issues and mitigate their impact on patients in order to improve the patient experience.
These teams also address any risks of our medicines being counterfeited or diverted by regularly providing education and training to employees, health care providers and law enforcement officials in higher-risk geographies.
We have robust systems in place to ensure the products we manufacture are high quality and available when customers and patients need them. Expert teams oversee every aspect of our processes, from discovery and development through manufacturing and delivery.
In addition to internal control measures, our quality processes are reviewed, certified and audited by multiple external regulatory authorities and notified parties. We use an integrated enterprise quality management system that complies with all applicable Canadian standards and regulations.
We ensure patients and customers continue to receive uninterrupted supply of the products they need, even in unpredictable circumstances, by identifying and qualifying backup suppliers, scanning the environment for potential risks and doing scenario planning.
You will be leaving your country’s AbbVie site and will be redirected to another country’s website. The AbbVie’s web site to where you will be redirected is exclusively designed for residents of particularly one or various countries, as announced in such web site. As a result, the website where you will be directed may contain pharmaceutical products information or other information that is not approved in other countries, regions or even in your country or territory of reference. If you live in a country other than those to which the site is directed, please contact your local AbbVie affiliate for the correct information on the products of your country of residence.